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.
Abstract
The activation, localization, phenotypic changes, and function of CFSE-labeled naive influenza-specific CD8+ and CD4+ T cells following influenza infection were examined. Response of adoptively transferred CD8+ T cells was seen earliest in draining lymph
node. Highly activated cells were found later in the lung, airways, and spleen, were cytolytic, and expressed IFN-γ upon restimulation. Similar amounts of division at early time points, but higher numbers of CD8+ T cells, were detected at 9 and 30 days postinfection after cotransfer of CD4+ and CD8+ T cells followed by infection. Transfer of much smaller numbers of CD4+ and CD8+ T
cells led to more extensive expansion but the same difference in final number between the two cell types. These studies demonstrate how CD8+ and CD4+ T cells respond to influenza at early time points postinfection and the differential kinetics of antigenspecific CD4+ and CD8+ T cells.
Keywords: virus infection, T lymphocytes, cellular activation, cellular proliferation, cell surface molecules
Abbreviations: BAL, bronchoalveolar lavage; DLN, draining lymph nodes; NDLN, nondraining lymph nodes; HA,
hemagglutinin

cific populations but is limited in the early phase of the
response by the low precursor frequency of responding
cells [11–13]. Adoptive transfer of antigen-specific lymphocytes counters this weakness and has been used to
monitor the T cell response to viruses such as LCMV
[14], VSV [15], influenza [16–18], and also responses to
ovalbumin [19, 20]. The respective roles of CD4+ and
CD8+ cells during infection by influenza have been investigated using knockout or depletion approaches [21–
26], but these studies did not examine respective rates of
activation or division of the CD4+ and CD8+ T cells. The
analysis of CD4+ and CD8+ T cell responses side by side
during pathogen infection has not been attempted until
recently [27, 28].
Previous work from our laboratory showed that Tc1
and Tc2 effector CD8+ lymphocytes were able to protect
mice from a lethal influenza infection [16], and we compared the efficacy of protection by naive, effector, and
memory populations [17]. In previous studies, we transferred large numbers (5 × 106) of CFSE-labeled naive influenza-specific TCR transgenic CD4+ from HNT mice

Introduction
Naive T cells become activated upon encounter with
peptide antigen on the surface of antigen presenting cells
in association with MHC molecules and then proliferate
and differentiate to become effector cells [1, 2]. Most effectors die, but a minority become long-lived memory
cells [3]. The surface phenotype changes as CD4+ and
CD8+ T cells progress from naive to activated effectors
and memory cells, with the gain of CD25, CD44, and
CD43 and loss of CD62L (reviewed in [4, 5]). Some activated T cells can gain cytotoxic activity and secrete
cytokines such as IFN-γ and TNF-α [6, 7], while others
gain the ability to provide B cell help [4, 8, 9]. The actual
events that regulate these processes are not fully understood, and much of our knowledge of T cell activation
has been gained from in vitro studies and may not be
fully applicable in vivo.
Following influenza infection in vivo, both CD8+ and
CD4+ T cells are activated (reviewed in [10]), and the use
of tetramers has improved the tracking of antigen-spe89
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and showed that after influenza infection, activated donor cells were detected in the spleen, lung, and bronchoalveolar lavage (BAL) in large numbers. The phenotypic changes increased with each division, and only
cells that had gone through multiple divisions and expressed an activated phenotype were found in the lung
and BAL [18].
Our primary goal here was to document the response
of CD8+ T cells in response to sublethal influenza infection and to compare the response of CD4+ and CD8+ T
cells. We demonstrate, using adoptive transfers of influenza-specific CD8+ and CD4+ T cells that both CD8+ and
CD4+ T cells were found to divide first in the draining
lymph nodes (DLN) and were then subsequently found
in lung, BAL, and spleen. Cotransfer of CD4+ and CD8+
T cells demonstrated that the CD8+ T cells expanded
to and were maintained for 30 days at higher numbers
than CD4+ T cells. CFSE-monitored division was not significantly different in CD8+ T cells compared with CD4+
T cells. Adoptive transfer of smaller numbers of CD8+
and CD4+ T cells resulted in similar peak numbers of
cells as with larger transfer doses, confirming that the
two cell types are regulated differently. Uniquely, adoptive transfer allows the analysis of the early phase of the
response where T cell division and phenotypic change
can be examined in the DLN and allows manipulation
of the number of input cells.
Materials and methods
Mice
BALB/c Thy1.1+ (gift from Dr. C. Suhr, Scripps Institute, La Jolla, CA), BALB/c (Thy1.2+) hemagluttinin (HA)-specific clone-4 TCR transgenic (gift from
Dr. L. Sherman, Scripps Institute), BALB/c HNT CD4+
TCR transgenic mice (gift from Dr. D. Lo, Scripps Institute), (BALB/c HNT × Thy1.1+) F1, and (BALB/c HA ×
Thy1.1+) F1 mice were bred at the Trudeau Institute animal breeding facility. HA clone-4 mice recognize the
peptide (IYSTVASSL) residues 518-26 from the hemagglutinin gene of influenza virus PR8 presented on H2Kd [29]. BALB/c HNT mice are CD4+ transgenic mice
that recognize peptide (HNTNGVTAACSHE), residues
126-138, from HA in the context of I-Ad [30]. BALB/c
Thy1.2+ mice were purchased from the Jackson Laboratory (Bar Harbor, ME). All animal procedures were done
in accordance with guidelines from the Institute Animal
Care and Use Committee (IACUC) at Trudeau Institute.
Cell culture medium
Cells were washed in RPMI with 1% FCS, 1 mM sodium pyruvate, 200 U/ml penicillin, 200 μg/ml streptomycin, 0.4 mM glutamine, 0.1 mM nonessential amino
acid solution (Gibco Invitrogen Corporation, Grand Island, NY). Tissue culture medium (TCM) was wash me-
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dia with 5% FCS and 4.5 × 10−5 M 2-mercaptoethanol
(Sigma, St. Louis, MO). P815 cells for cytotoxicity assays
were maintained in DMEM with high glucose (Irvine
Scientific, Santa Ana, CA) supplemented with penicillin/streptomycin and 10% FCS [16].
Cell preparation and adoptive transfer
Single cell suspensions of CD8+ cells were prepared
from cervical, inguinal, axillary, and brachial lymph
nodes and spleens from clone-4 TCR transgenic Thy1.2+
mice. Cells were purified by positive selection with antiCD8α beads using MACS columns according to manufacturer’s protocol (Miltenyi Biotech, Auburn, CA) and
then centrifuged on a four-layer Percoll (Sigma) gradient to remove activated cells [16]. CD4+ cells were prepared from HNT mice using antibody and complement
depletion followed by a Percoll gradient [31] or by positive selection on MACS columns followed by centrifugation on Percoll as for CD8. Naive CD8+ and CD4+ T
cells were over 90% pure and were not contaminated by
significant numbers of other T cells or B cells. They expressed high levels of CD62L, low levels of CD25, and
intermediate levels of CD44 (data not shown). Cells
were counted using an ACT10 Coulter counter (Becton Coulter, Brea, CA) or trypan blue dye exclusion. Injected intravenously into the lateral tail vein of BALB/
c Thy1.1+ recipients were 5 × 106 CFSE-labeled Thy1.2+
CD8+ cells in 500 μl PBS (Gibco). For cotransfer experiments, 3 × 106 Thy1.2+ HA mixed with 3 × 106 Thy1.2+
HNT CFSE-labeled cells in 250 μl PBS were injected into
Thy1.1+ BALB/c mice. In some experiments, cells from
HA (Thy1.1+ × 1.2+) F1 or HNT (Thy1.1+ × 1.2+) F1 mice
were injected into BALB/c Thy1.2+ recipients. No significant differences were seen between transferring Thy1.2
into Thy1.1 and Thy1.2 × Thy1.1 into Thy1.2 mice.
CFSE labeling
CFSE (Molecular Probes, Eugene, OR) was stored at
−20°C in DMSO (Sigma) at a concentration of 10 mM.
Cells were labeled with a 1/4000 dilution of the stock
diluted 1:1 with cells at 2 × 107/ml in PBS and incubated
for 8 min at RT. Cells were then quenched with FBS and
washed three times with PBS [32].
Influenza virus and infections
Influenza Puerto Rico (PR8) (H1N1) virus (a gift from
Drs. D. Morgan and L. Sherman) was grown in the allantoic fluid of embryonated hens eggs as described in
Refs. [18 and 33]. Mice were infected with influenza by
intranasal inoculation of 50 or 100 μl of virus in PBS.
A sublethal dose of 15000 EIU (0.5 LD50 determined
in BALB/c mice) or 6000 EIU (0.2 LD50) was routinely
given, 16–20 h after adoptive cell transfer. Control mice
were given 50 μl PBS intranasally.
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Tissue sampling and flow cytometry of surface markers
Mice were sacrificed by exsanguination under deep isofluorane inhalation anesthesia at various time points after influenza infection, and spleen, the nondraining axillary, and brachial and inguinal lymph nodes (NDLN)
were taken. Bronchoalveolar lavage (BAL) was collected by washing the airways four times with 0.5 ml
10 mM EDTA (Sigma) in PBS. Lungs were removed following perfusion with 5 ml PBS via the left ventricle of
the heart. Finally, the draining mediastinal and parathymic draining lymph nodes (DLN) were collected.
Single cell suspensions were prepared using 70-μm nylon filters (Falcon, Franklin Lakes, NJ). The cells were
washed and resuspended in FACS buffer [PBS with 2%
(w/v) BSA (Intergen, Purchase, NY) and 0.1% (w/v)
sodium azide (Sigma)] then incubated with 1 μg antiFcR (clone 2.4G2, produced by Trudeau Institute) followed by anti-CD8-PerCP (53-6.7), or anti-CD4-perCP
(RM4-5) anti-Thy1.2-APC (53-2.1), and one of a number
of PE-labeled conjugates: anti-CD62L (MEL-14), antiCCR5 (C34-3448), anti-CD44 (IM7), anti-CD25 (PC61,
Caltag, Burlingame, CA), anti-CD43 (1B11), anti-CD69
(H1-2F3) anti-Vβ8.1/8.2 (MR5-2), and anti-Ly6C (HK14), all obtained from BD Biosciences, San Diego, CA,
except where noted. Cells were then washed and analyzed on a four-color FACSCalibur (BD Biosciences,
San Jose, CA) using CellQuest software. Profiles were
analyzed using FlowJo (Treestar, San Carlos, CA) by
determining the percentage of CD8+ Thy1.2+ lymphocytes. The number of donor cells was calculated by
multiplying the percentage CD8+Thy1.2+ cells in the
FlowJo live gate by the percentage of live cells and by
the number of lymphocytes calculated by the Coulter
counter.
Intracellular cytokine staining
Single cell suspensions from various organs were cultured in TCM with 11 μM HA peptide (W. Alton Jones
Cell Science Center, Lake Placid, NY) overnight with 10
μg/ml Brefeldin A (Sigma) added after the first 4 h. The
cells were harvested and incubated with anti-IFN-γ-PE
(XMG1.2) or anti-TNF-α-PE (MP6-XT22), both from BD
Biosciences, in saponin buffer (0.1% saponin from Quillaja Bark, Sigma) in PBS [34]. The cells were then processed as above for surface staining of Thy1.2 and CD8
and analyzed by flow cytometry.
Virus titer
Mice injected with CD8+ T cells and influenza-infected
were euthanized at various times postinfection by cervical dislocation. The lungs were removed, snap-frozen in
liquid N2, and stored at −70°C. The lungs were thawed,
homogenized, and the influenza titer determined using
the Madine Darby Canine Kidney (MDCK) cell plaque
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assay as detailed previously [17]. Plaque-forming units
(PFU) are expressed per lung.
Cytotoxicity assay
Single cell suspensions were prepared from mice adoptively transferred with CD8+ T cells and infected with
influenza. B cells were depleted from spleen with antiB220 beads using MACS columns according to manufacturer’s instructions (Miltenyi Biotech). Lung cells were
enriched for lymphocytes by centrifugation on Lympholyte-poly (Cedarlane, Hornby, Canada) and then incubated with anti-Thy1.2 beads. Thy1.2+ and Thy1.2− populations were obtained from these cells using MACS
columns (Miltenyi Biotech). 51Cr-labeled P815 cells (Perkin Elmer NEN, Boston, MA), 1 × 104, pulsed or unpulsed with HA peptide were incubated with Thy1.2+ or
Thy1.2− lung cells, B cell-depleted splenocytes, DLN, or
NDLN cell populations for 4 h as described previously
[16]. Maximum lysis was determined by incubation with
0.1% Triton X 100 (Sigma) and spontaneous lysis by incubation in medium alone. The percentage lysis was calculated by (experimental–spontaneous lysis/maximum
lysis–spontaneous lysis) × 100. Spontaneous lysis of unpulsed P815 cells was <20% in all wells.
Results
The expansion and localization of adoptively transferred HA
peptide-specific TCR transgenic naive CD8+ T cells vary between lymphoid and nonlymphoid sites
We first assessed the magnitude of the response of
naive HA peptide-specific CD8+ TCR transgenic T
cells to an influenza infection. Naive donor HA-specific CD8+ T cells were transferred into BALB/c mice
subsequently infected 16–20 h later with PR8 influenza. At various times postinfection, we analyzed single cell suspensions from five tissues: DLN (mediastinal and parathymic lymph nodes), NDLN (axillary,
brachial, and inguinal lymph nodes), spleen, airways
[bronchoalveolar lavage (BAL)], and lung. The absolute numbers of CD8+ donor cells detected in each set
of tissues are shown on a logarithmic scale in Figure
1A. The time of the peak CD8+ response was similar
in DLN, spleen, BAL, and lung, 8 to 9 days postinfection (Figure 1A and data not shown). Significant populations of donor cells were found in the DLN at Day 4
postinfection with no cells in lung and BAL at this time
point. At Days 6 and 8 postinfection, high numbers of
donor cells were found in lung and lower numbers in
spleen and DLN. Numbers of donor cells declined in
all organs by Day 29 postinfection with the exception
of the NDLN. These data together indicated that the
donor cell accumulation was focused near to the site of
infection, the lung.
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Figure 1. Adoptively transferred CD8+ TCR transgenic T cells expand and then decline after influenza virus infection and mice clear
the virus with concurrent loss and gain of body weight. (A) Thy1.2+ CFSE-labeled naive clone-4 HA CD8+ transgenic T cells, 5 × 106,
were adoptively transferred into Thy1.1+ syngeneic recipients infected intranasally 18 h later with 0.5 LD50 influenza. (A) Mice were
sacrificed at indicated times, and the number of donor cells from draining lymph nodes (DLN), nondraining lymph nodes (NDLN),
spleen, lung tissue, and brochoalveolar lavage (BAL) was determined by flow cytometry. Values shown are mean ± SD of three to
six mice per group. These data are from a representative experiment repeated eight times with similar results. (B) Lung virus load
(units shown are PFU per lung and dotted line indicates limit of detection) and (C) mouse weight with adoptive transfer of 7 × 105
naive CD8+ T cells or PBS and 3000 EIU influenza infection. Results are from one representative experiment of three.

To compare the extent of proliferation in various tissues, we calculated the numbers of adoptively transferred CD8+ T cells recovered from mice sublethally infected with influenza or mock-infected with PBS. To
quantify the extent of the expansion of CD8+ T cells
brought about by influenza infection, we divided the
number of adoptively transferred cells recovered from
infected mice by the number of adoptively transferred
cells recovered from uninfected controls. The result is
shown in Table 1. Large numbers of cells are generated
early in the response in the draining lymph node, and
the action moves later to the lung and then to the BAL.

Virus is cleared and weight loss is restored following the appearance of T cells in the lung and BAL
The presence of influenza virus in the lungs was measured using a plaque assay. Figure 1B shows that the viral titer in the lungs of mice after adoptive transfer of
HA peptide-specific CD8+ T cells followed by influenza
infection is high from Days 2 to 6 postinfection and then
decreases. The peak of cell numbers in the lung and BAL
therefore correlates with clearance of virus from the
lungs. Figures 1B and C show that the weight loss and
viral clearance did not significantly differ in mice that
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Table 1. Influenza infection leads to increased numbers of donor lymphocytes in DLN, lung, and BAL compared with uninfected controls
Days
postinfectiona

Organ sampledb
DLN
NDLN

Day
Day 7
Day 11

47.11c

4
322.51
90.95

0.25
0.27
0.002

Spleen
0.28
13.7
0.71

Lung
0.84
1651
620

BAL
6.22
17.062
58.752

a Days postinfection with influenza.
b Organs were taken from euthanized mice and donor cell

numbers determined using flow cytometry.

c The ratio of numbers of cells recovered from mice given 5 ×

106 HA clone-4 naive transgenic T cells at Day –1, infected
with influenza divided by mice given PBS intranasally.
Numbers are the ratio of three infected animals per group
divided by three uninfected animals. Representative experiment repeated three times.
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by loss of CFSE, and have a progressively activated phenotype with gain of activation-associated markers in the
DLN, NDLN, and spleen. The cells that enter the lung
and BAL all have low CFSE intensity, indicating that
more than seven divisions have occurred, and possess
high surface expression of CD43, CD44, CD25, and Ly6C
and low CD62L. The level of CD25 on the donor cells
found in the DLN at Day 8 postinfection is lower than
that seen at Day 4, but other activation markers (CD43
and CD44) remain high at this time. The donor cells also
expressed increased levels of CD54, CD11a, and CD49d
upon activation (data not shown). In addition, the transgene TCR Vβ is expressed at high levels during the response, and there are a subset of cells present in the lung
that express CCR5 (data not shown).

did not receive donor cells, indicating that the adoptively transferred lymphocytes did not significantly
accelerate viral clearance over the rate seen in the untreated host.
CFSE-labeled CD8+ T cells divided early during infection in
the DLN and changed cell surface phenotype
The influenza-specific T cell precursor frequency is very
high following the adoptive transfer of large numbers of
antigen-specific cells allowing a detailed analysis of the
early events that are below the level of detection using
tetramer analysis. At Days 2 and 3 postinfection, all donor cells retained high levels of CFSE in all organs examined (data not shown) indicating that division had
not yet begun. As shown in Figure 2A, donor cells have
already divided up to seven times in the DLN by Day 4
postinfection; in contrast, low levels of cell division are
seen in the spleen and no division in NDLN. The surface expression levels of CD43, CD44, and CD25 increased as the cells divided in the DLN but are still low
in the spleen and NDLN at this time point. Adoptively
transferred cells recovered from the DLN decrease cell
surface expression of CD62L as the cells divide, but expression of this marker remains high on undivided cells
recovered from NDLN and spleen. The Ly6C phenotype
was low to intermediate in all tissues at Day 4. CD69
cell surface expression is increased initially on cells recovered from the DLN and then decreases as the cells
divide (data not shown). The cell division and gain of
an activated phenotype are seen first in DLN, and cells
with an activated phenotype are found in other lymphoid and nonlymphoid organs at later time points.
Adoptively transferred CD8+ HA peptide-specific T cells possess an activated phenotype at the peak of cell accumulation
Figure 2B shows that virtually all of the adoptively transferred CD8+ T cells have divided by Day 8, as measured

Figure 2. Adoptively transferred CD8+ T cells show division
and gain of activation-associated molecules in the DLN at Day
4 postinfection and possess a highly activated phenotype at
Day 8 postinfluenza. Cells were transferred and mice infected
with influenza as described in Figure 1. (A) Four and (B) eight
days later, mice were euthanized. Cells from DLN, NDLN,
spleen, lung tissue, and BAL were analyzed by flow cytometry. Profiles shown are gated for cells that are CD8+Thy1.2+.
Results are one mouse in a group of three from a representative experiment repeated eight times with similar results.
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Figure 3. Adoptively transferred CD8+ T cells are able to make IFN-γ upon restimulation and are immediately cytotoxic ex vivo.
Thy1.2+ CFSE-labeled naive clone-4 HA CD8+ transgenic T cells were adoptively transferred into Thy1.1+ recipients followed 18
h later by influenza infection. Mice were sacrificed 4 (A) or 6 (B) days postinfection, and cells from various organs were incubated
with or without HA peptide overnight followed by intracellular cytokine staining. (C) Seven days postinfection, cytotoxicity of
cells from various organs was tested in a 51Cr release assay. E:T ratios are calculated on the number of Thy1.2 donor cells in the
sample. Results shown are one representative experiment of (A, B) three and (C) two.

Adoptively transferred CD8+ cells can produce IFN-γ in response to specific influenza peptide and are cytotoxic immediately ex vivo
Cytokine expression by donor CD8+ CFSE-labeled T
cells was examined ex vivo by flow cytometric intracellular cytokine staining to document the acquisition
of effector function in the donor cells [35, 36]. IFN-γ expression by donor cells at Days 4 and 6 postinfection
is shown in Figures 3A and B. Cells recovered at Day
4 showed significant IFN-γ expression in DLN, mostly
from divided cells, but there was some IFN-γ expression
in spleen and NDLN. At Day 6, cells from all organs examined produced intracellular IFN-γ in response to peptide, and the majority of these IFN-γ positive cells had
divided many times (low CFSE intensity). The highly di-

vided cells are also capable of producing TNF-α at Days
6 and 8 postinfection (data not shown).
To further characterize the effector function, we investigated whether donor cells were able to lyse peptide
pulsed target cells in an ex vivo 4-h chromium release
assay, isolated and tested without restimulation. As
shown in Figure 3C, the immediate ex vivo HA peptidespecific CTL activity is similar for donor cells recovered
from the lungs and spleen where high amounts of cytotoxicity were found. Cells recovered from the DLN were
less cytotoxic, and cells from NDLN were without activity. Thus, the adoptively transferred CD8+ T cells develop the surface phenotype and ex vivo function consistent with highly activated influenza-specific effectors
in the influenza-infected host.
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Figure 4. Adoptively transferred CD8+ lymphocytes possess
a resting phenotype at Day 29 postinfection. Cells were transferred and mice infected with influenza as described in legend to Figure 1. After 29 days, cells from DLN, NDLN, spleen,
lung, and BAL were analyzed by flow cytometry. Results are
one mouse in a group of three from a representative experiment repeated eight times with similar results.

Adoptively transferred CD8+ T cells still present at Day 30
postinfection are able to make cytokines upon restimulation
in vitro
We had seen earlier that significant numbers of CD8+
lymphocytes persisted until at least Day 29 postinfection
(Figure 1), and so the phenotype and CFSE intensity of
these CD8 T cells were analyzed by flow cytometry as
shown in Figure 4. The surface phenotype of these cells
was significantly different from that seen during the effector phase. Resting CD8+ cells recovered from DLN,
NDLN, and spleen expressed both high and low surface
levels of CD62L, while CD8 T cells recovered from BAL
and lung expressed low surface levels of CD62L. The
cells in the lymphoid tissues had also decreased surface
expression of CD43, but the majority of cells recovered
from the lung maintained high surface expression of
CD43. The expression of Ly6C was high to intermediate
in lymphoid tissues and mixed medium and low in lung
and BAL. The CD25 expression was low in all tissues examined, and CD44 remained high. The adoptively transferred CD8+ T cells persisting at Day 34 made IFN-γ and
TNF-α when stimulated with HA peptide overnight, as
shown in Figure 5. These cells resemble memory cells
and produce cytokines after in vitro stimulation.
Cotransfer experiments showed that CD4+ T cells expanded
less than CD8+ T cells and that the CD4+ T cells decline more
rapidly
The numbers and accumulation kinetics we had found
for CD8+ T cells differed from that previously found for
CD4+ T cells [18]. It was therefore important to compare
the recruitment and proliferation of adoptively trans-
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ferred CD4+ and CD8+ T cells in the same animal to determine whether there were significant differences during influenza infection. We adoptively transferred 3 ×
106 CFSE-labeled naive CD4+ HNT T cells and 3 × 106
CFSE-labeled naive CD8+ HA T cells into the same Thy1 disparate host and enumerated these cells in the five
sets of tissues at various times after influenza infection.
Neither CD4+ nor CD8+ T cells were present in the
lungs or BAL in significant numbers on Day 4 (Figure
6A). At Day 7, both cell types appeared in the lung, and
BAL and had downregulated CD62L surface expression
(data not shown). The CD8+ donor cell numbers within
the DLN were higher than that of CD4+ T cells, higher in
the lung, and comparable in the spleen. The number of
CD8+ T cells peaked 10-fold higher in the lung at Day 9,
and the peak of the response was later than that seen for
donor CD4+ cells. The subsequent decline of the CD4+ T
cells was more pronounced than that of CD8+ T cells in
the lung and BAL. In addition, there were many folds
more CD8+ than CD4+ T cells in the lung and BAL at
Day 30 postinfection, but more similar numbers of CD4+
and CD8+ T cells were seen in spleen, DLN, and NDLN.
FACS profiles of CFSE-labeled donor cells recovered at
Days 4 and 7 postinfection are shown in Figure 6B, demonstrating that CD4+ and CD8+ T cells divide similarly
in response to influenza infection. (In the figure, CD4+ T
cells are scored as CD8−, but the same picture was seen
when cells were stained with anti-CD4, and CD8+ cells
were scored as CD4−, data not shown). Both adoptively
transferred CD4+ and CD8+ cells gained surface expression of CD43 and lost surface expression of CD62L concurrently with increasing number of divisions (data
not shown). The cotransfer experiments confirmed that
CD8+ T cells expanded more than CD4+ T cells, that the
CD8+ T cell response was more prolonged, and that the
higher number of CD8+ effectors at the peak was followed by higher numbers of persisting memory cells at
Day 30 postinfection.
Adoptive cotransfer of decreasing numbers of CD8+ and
CD4+ T cells shows that smaller numbers of CD8+ T cells expand to a greater extent than small numbers of CD4+ T cells
We were concerned that the high numbers of cells used
in the adoptive transfers might lead to artificially high
numbers of cells recovered and inefficient activation. In
other studies, we found that adoptive transfer of small
numbers (102) and large numbers (107) of naive transgenic CD8+ T cells with peptide pulsed dendritic cells resulted in similar numbers of antigen-specific cells recovered at Day 7 after transfer (Kemp et al., unpublished).
We concluded that it should be possible to follow the
later stages of the response in the current studies using
much lower number of naive donor cells and determine
whether kinetics of accumulation between CD4+ and
CD8+ T cells were still different beginning with a lower
number of cells.
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Figure 5. Adoptively transferred cells recovered at Day 34 postinfection are able to make IFN-γ and TNF-α upon in vitro stimulation.
Cells were transferred and mice infected with influenza as described in legend to Figure 1. After 34 days, mice were sacrificed and
cells from DLN, NDLN, spleen, lung, and BAL were incubated overnight followed by intracellular cytokine staining for (A) IFN-γ
and (B) TNF-α. Results are one mouse in a group of two from a representative experiment repeated twice with similar results.

We transferred varying numbers of CD4+ and CD8+
cells into the same animal and compared the numbers
found in various organs after at different time points
postinfection. As shown in Figure 7, we again found that
the number of both CD4+ and CD8+ T cells recovered at

later time points was not proportional to the numbers
injected but converged towards the same peak level. The
greater expansion and localization to the lung of CD8+ T
cells than CD4+ were still apparent at the intermediate
and lowest input dose. The overall kinetics of the two

Figure 6. CD8+ T cells possess more prolonged expansion and reach higher numbers than CD4+ T cells, but division is similar after influenza infection. Thy1.2+ CFSE-labeled naive HNT CD4+ transgenic T cells, 3 × 106, and Thy1.2+ CFSE-labeled naive clone-4
HA CD8+ transgenic T cells, 3 × 106, were adoptively transferred into Thy1.1+ recipients followed 18 h later by influenza infection.
(A) Mice were sacrificed at indicated times and cells from DLN, NDLN, spleen, lung, and BAL were analyzed by flow cytometry
and the number of cells in each organ calculated. Values shown are mean ± SD of three mice per group. (B) CFSE profiles versus
CD8+ staining in donor cells isolated at Days 4 and 7 postinfection. These are representative data from one experiment repeated
five times with similar results.
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Figure 7. Titration of donor cells reveals similar dose-dependent kinetics between CD4+ and CD8+ T cell accumulation after influenza infection in vivo. Graded numbers of (Thy1.1+ × Thy1.2+) F1 CD4+ and CD8+ T cells were mixed and adoptively transferred
into Thy1.2+ recipients subsequently infected with influenza (6000 EIU). The number of donor Thy1.1+ CD8+ (A) or CD4+ (B) T
cells was calculated from DLN, spleen, and lung. Values shown are mean ± SD of four mice per group. These data are from a representative experiment repeated twice with similar results.

responses are similar for the CD4+ and CD8+ T cell populations. Therefore, we find that decreasing the numbers
of adoptively transferred cells confirms the observation
that CD8+ T cells reach a higher peak number than CD4+
T cells in the lung, and these increased numbers also occur with smaller numbers of input cells.
Discussion
We have shown here that adoptively transferred CFSElabeled HA peptide-specific TCR transgenic CD8+ T
cells are found to have begun to divide first and produce
IFN-γ in the DLN, then at later time points are detected
in large numbers in the lung, BAL, and spleen in response to influenza infection. Highly activated effectors
recovered from the lung are able to kill peptide pulsed
targets ex vivo and are able to produce cytokines upon
in vitro restimulation. The surface phenotype of these
cells differs in various tissues and changes as the cells
divide. The expression of CD25, CD43, CD44, and several other adhesion molecules becomes elevated, while
the expression of CD62L declines. When the activation
of CD4+ and CD8+ T cells in response to influenza were
compared directly in the same mouse, both cell types
were initially found in large numbers in the DLN and

at later time points in the lung, BAL, and spleen. The
gain of effector phenotype and CFSE-monitored cell division was similar in both CD4+ and CD8+ T cells. CD8+
T cells expanded to higher numbers than CD4+ T cells,
and the decline in number of CD8+ T cells after the peak
was more gradual. The number of recovered CD8+ and
CD4+ T cells drops dramatically in all organs sampled
after virus has been cleared, but a residual population of
adoptively transferred memory cells is detectable until
at least Day 30 postinfection.
Adoptively transferred influenza HA-specific CD8+ T
cells in the DLN divide and express increasingly high levels of CD25, CD43, and CD44 and lower levels of CD62L
at 4 days postinfection. These changes are not seen in cells
found in the spleen and NDLN at Day 4 suggesting that
the HA-specific cells are initially activated in the draining
lymph nodes which had been proposed before from cell
accumulation data [21]. At later time points, the HA-specific cells possess an activated phenotype in all organs examined. The cells in the lung and BAL have higher levels
of CD25 and CD43 and lower levels of CD62L correlating well with the higher cytotoxic activity of cells isolated
from the lung. The different populations of cells in the
two locations could represent different subsets of effectors or cells at different activation states.
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Cell division is generally correlated with activation
for both CD4+ and CD8+ T cells [6, 37, 38] but may not
be the case with activation-induced tolerance [39]. We
address this question directly using CFSE and surface
activation markers and find that division correlates with
activation in this infection (Figure 2 and Figure 3). Cytotoxic cells were recovered from the lungs and spleen,
and these populations consisted an overwhelming majority of divided cells. Undivided cells express elevated
levels of CD69 (data not shown) and can produce cytokines upon restimulation in vitro (Figure 3), suggesting that these cells are partially activated as recently reported by others [38].
CD43 expression declines in the lymphoid tissues but
remains high in the lung and BAL at Day 30 and highlights differences between lymphocytes persisting in the
lungs/BAL and lymphoid tissues [40 and 41]. Previous
studies had only shown CD43 decline in the spleen [42].
The Ly6C expression on naive cells consists both a positive and negative population, the significance of which
is unclear [3]. Here, we show an increased surface level
of Ly6C during influenza infection which is similar to
anti-CD3 activation in vivo [43]. Ly6C remains high on
memory CD8+ cells in peripheral lymphoid tissues and
is mixed within the lung and BAL. Ly6C may play a role
in the trafficking of CD8+ lymphocytes [44], but the significance of the biphasic level of expression in the lung
is not clear but could indicate differential function or
migration ability.
The adoptively transferred CD8 T cells develop effector function, but this differs in cells from different locations. We found high levels of ex vivo CTL activity in
cells from the lung and spleen, but little or no activity
in cells from the DLN and NDLN. CTL activity in cells
from the influenza-infected lung has been reported previously [13, 33]. This lack of CTL activity in DLN agrees
with Johnson et al. [45], but they also found low CTL activity in the spleen. The higher numbers of CTL in the
spleen after adoptive transfer and infection may reflect higher numbers of activated cells accumulating or
that the adoptively transferred cells have better access
to antigen and therefore are more highly activated. The
adoptively transferred cells are able to make IFN-γ and
TNF-α, as previously found using tetramers to identify
influenza-specific CD8+ T cells [7]. Our data indicate
that IFN-γ is acquired early in the response before cells
have divided showing that IFN-γ is switched on earlier
than previously appreciated.
Recent suggestions have been made that CD8+ T cells
proliferate more rapidly than CD4+ T cells [2, 27, 28]. In
our experiments, we followed the expansion of CFSE-labeled CD4+ T cells and CD8+ T cells in the same mouse.
Our data are in agreement with that found by Homann
et. al. [27] who reported that CD4+ and CD8+ T cells expanded to a peak at a similar rate, but the number of
CD4+ cells decline more rapidly after the peak. We have
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also confirmed the same difference between the two cell
types, using very much lower initial number of CD4+ or
CD8+ T cells demonstrating that both cell types were capable of perhaps 10000-fold expansion, but total numbers were lower for CD4+ T cells than CD8+ T cells indicating that these two populations were regulated
differentially after the first five to six divisions. The cells
that persist 30 days after adoptive transfer express low
levels of CD25 indicating resting memory cells [3]. The
higher numbers of CD8+ than CD4+ we see at Day 30
are in agreement with recent studies that suggest that
CD8+ T cells are more stable as memory cells than CD4+
T cells after respiratory infection [46]. The mechanism of
differential survival of CD4+ and CD8+ T cells after influenza infection is unclear but could be due to differential expression of Bcl2 as proposed for LCMV [27]. Other
mechanisms could be that the cells are responding to different costimulatory signals such as OX40 [47] or CD27
[48] or different amounts of persisting antigen presented
by MHC class I or II molecules [49]. The TCR transgenic
cells may not reflect all populations of antigen-specific
cells because immunodominance and antigen affinity
may affect the relative kinetics of the two populations
[50, 51]. Examination of host CD8+ and CD4+ T cell responses to influenza infection indicates that the CD8+
T cells predominate in the lungs as seen with the adoptive transfer studies (data not shown). Also, these data
shown here agree with studies analyzing antigen-specific CD4+ and CD8+ T cells after Sendai virus infection
[46].
In summary, we have described an adoptive transfer
system that allows the visualization of both the early and
late stages of antigen-specific CD4+ and CD8+ T cell response during influenza infection in the same recipient.
We have been able to demonstrate the relative kinetics of
an antigen-specific population of both CD4+ and CD8+
T cells responding to influenza infection. The phenotypic changes that occur and localization of the cells into
the lung and BAL are similar for both CD4+ and CD8+
T cells. Both CD4+ and CD8+ immune responses to influenza appear to be initiated in draining lymph nodes.
The responding cells undergo similar changes in the expression of cell surface markers. The CD4+ and CD8+ T
cells appear to divide at a similar rate, but CD8+ T cells
increase to 10-fold more than CD4+ T cells. The CD8+ T
cells continue to expand after the CD4+ T cells peak and
then decline in numbers more slowly than CD4+ T cells.
Thus, CD4+ and CD8+ T cells are regulated differentially
to perform distinct functions, and this adoptive transfer
system is ideal to investigate these responses.
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